Cargando…

Emergence of Minor Drug-Resistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission

BACKGROUND: WHO-guidelines for prevention of mother-to-child transmission of HIV-1 in resource-limited settings recommend complex maternal antiretroviral prophylaxis comprising antenatal zidovudine (AZT), nevirapine single-dose (NVP-SD) at labor onset and AZT/lamivudine (3TC) during labor and one we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hauser, Andrea, Sewangi, Julius, Mbezi, Paulina, Dugange, Festo, Lau, Inga, Ziske, Judith, Theuring, Stefanie, Kuecherer, Claudia, Harms, Gundel, Kunz, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285650/ https://www.ncbi.nlm.nih.gov/pubmed/22384138 http://dx.doi.org/10.1371/journal.pone.0032055

Ejemplares similares

Comparison of 454 Ultra-Deep Sequencing and Allele-Specific Real-Time PCR with Regard to the Detection of Emerging Drug-Resistant Minor HIV-1 Variants after Antiretroviral Prophylaxis for Vertical Transmission
por: Hauser, Andrea, et al.
Publicado: (2015)

Adherence to Combination Prophylaxis for Prevention of Mother-to-Child-Transmission of HIV in Tanzania
por: Kirsten, Inga, et al.
Publicado: (2011)

Zidovudine Exposure in HIV-1 Infected Tanzanian Women Increases Mitochondrial DNA Levels in Placenta and Umbilical Cords
por: Kunz, Andrea, et al.
Publicado: (2012)

Hematological Changes in Women and Infants Exposed to an AZT-Containing Regimen for Prevention of Mother-to-Child-Transmission of HIV in Tanzania
por: Ziske, Judith, et al.
Publicado: (2013)

Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan Women after Nevirapine Single-Dose Prophylaxis
por: Hauser, Andrea, et al.
Publicado: (2011)

Official invitation letters to promote male partner attendance and couple voluntary HIV counselling and testing in antenatal care: an implementation study in Mbeya Region, Tanzania
por: Jefferys, Laura F., et al.
Publicado: (2015)

Increasing Partner Attendance in Antenatal Care and HIV Testing Services: Comparable Outcomes Using Written versus Verbal Invitations in an Urban Facility-Based Controlled Intervention Trial in Mbeya, Tanzania
por: Theuring, Stefanie, et al.
Publicado: (2016)

Outcome of Different Nevirapine Administration Strategies in Preventin g Mother-to-Child Transmission (PMTCT) Programs in Tanzania and Uganda
por: Karcher, Heiko, et al.
Publicado: (2006)

Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda
por: Rempis, Eva M., et al.
Publicado: (2017)

Sexual Risk Behavior in HIV-Uninfected Pregnant Women in Western Uganda
por: Theuring, Stefanie, et al.
Publicado: (2021)

Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT
por: Machnowska, Patrycja, et al.
Publicado: (2017)

The incidence of HIV and associated risk factors among pregnant women in Kabarole District, Uganda
por: Schumann, Hannah, et al.
Publicado: (2020)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

“In the hospital, there will be nobody to pamper me”: a qualitative assessment on barriers to facility-based delivery in post-Ebola Sierra Leone
por: Theuring, Stefanie, et al.
Publicado: (2018)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

Prevention of mother-to-child transmission of HIV: Postpartum adherence to Option B+ until 18 months in Western Uganda
por: Decker, Sarah, et al.
Publicado: (2017)

Novel Approaches to Postnatal Prophylaxis to Eliminate Vertical Transmission of HIV
por: Ruel, Theodore, et al.
Publicado: (2023)

Antiretroviral postnatal prophylaxis to prevent HIV vertical transmission: present and future strategies
por: Penazzato, Martina, et al.
Publicado: (2023)

Risk adapted transmission prophylaxis to prevent vertical HIV–1 transmission: Effectiveness and safety of an abbreviated regimen of postnatal oral Zidovudine
por: Neubert, Jennifer, et al.
Publicado: (2013)

Decay Kinetics of HIV-1 Specific T Cell Responses in Vertically HIV-1 Exposed Seronegative Infants
por: Holditch, Sara J., et al.
Publicado: (2012)

Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
por: Kalusche, Sarah, et al.
Publicado: (2020)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

Features of Maternal HIV-1 Associated with Lack of Vertical Transmission
por: Ahmad, Nafees, et al.
Publicado: (2017)

Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis
por: Camp, Christina, et al.
Publicado: (2021)

The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis
por: Roff, Shannon R., et al.
Publicado: (2014)

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion
por: Donnell, Deborah, et al.
Publicado: (2017)

Pre-exposure prophylaxis of HIV
por: Naswa, Smriti, et al.
Publicado: (2011)

Pre-exposure prophylaxis in HIV
por: Khambhati, Ravi, et al.
Publicado: (2009)

HIV: Pre-exposure Prophylaxis
por: Singh, Ajai Kumar, et al.
Publicado: (2012)

Latent profiles of stigma and HIV pre-exposure prophylaxis among Black sexual minority men: an exploratory study
por: Turpin, Rodman, et al.
Publicado: (2022)

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study
por: Grinsztejn, Beatriz, et al.
Publicado: (2023)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Non-Vertical Exposures to HIV, HBV and HCV Infection in Children and Adolescents—Risk of Infection, Standards of Care and Postexposure Prophylaxis
por: Tomasik, Anna, et al.
Publicado: (2021)

Modelling the evolution of HIV‐1 virulence in response to imperfect therapy and prophylaxis
por: Smith, David R. M., et al.
Publicado: (2017)

Characteristics of HIV-1 Serodiscordant Couples Enrolled in a Clinical Trial of Antiretroviral Pre-Exposure Prophylaxis for HIV-1 Prevention
por: Mujugira, Andrew, et al.
Publicado: (2011)

The use of preexposure treatments for HIV prophylaxis
por: Majid, Adrian, et al.
Publicado: (2012)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Modeling HIV Pre-Exposure Prophylaxis
por: Straubinger, Thomas, et al.
Publicado: (2020)

Prescribing pre-exposure prophylaxis for HIV
por: Bloch, Mark
Publicado: (2020)

Molecular characterization of the HIV-1 gag nucleocapsid gene associated with vertical transmission
por: Wellensiek, Brian P, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_0ac8mtpkk8bj2lmceuiioss9a8